机译:算法评估的MRI特征预测哪种患者对导管癌的术前诊断原位造成浸润乳腺癌?
Department of RadiologyDuke University School of Medicine Duke UniversityDurham North Carolina USA;
Department of RadiologyDuke University School of Medicine Duke UniversityDurham North Carolina USA;
Department of RadiologyDuke University School of Medicine Duke UniversityDurham North Carolina USA;
Department of MedicineDuke University School of MedicineDurham North Carolina USA;
Department of SurgeryDuke University School of MedicineDurham North Carolina USA;
Department of Surgical OncologyDuke University Medical CenterDurham North Carolina USA;
Department of RadiologyDuke University School of Medicine Duke UniversityDurham North Carolina USA;
breast cancer; ductal carcinoma in situ; MRI; upstaging; invasive carcinoma;
机译:算法评估的MRI特征预测哪种患者对导管癌的术前诊断原位造成浸润乳腺癌?
机译:术后术后预测术前术治疗导管癌(DCIS)术前术治疗导管癌(DCIS):多制度回顾队列研究
机译:导管癌初步诊断患者中浸润性乳腺癌的预测指标:选择性使用前哨淋巴结活检治疗导管癌的指南。
机译:乳腺MRI的基于深度学习的特征可预测导管癌的隐匿性浸润性疾病:初步数据
机译:14-3-3 Zeta介导的上皮-间质转化(EMT)有助于ErbB2过表达导管原位癌(DCIS)演变为浸润性乳腺癌
机译:通过算法评估的MRI特征是否可以预测哪些术前就诊为导管癌的患者被转移至浸润性乳腺癌?
机译:术后术后预测术前术治疗导管癌(DCIS)术前术治疗导管癌(DCIS):多制度回顾队列研究